- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Silke Gillessen and Aurelius Omlin introduce the expert panel and voting process, while patient advocate David Matheson discusses patients' illness and wellness experiences. He emphasizes hope's role in treatment and calls for more patient-centered quality of life measures. Biographies: Silke Gillessen, MD, President, APCCC, Medica...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Martin Gleave reviews risk stratification challenges in high-risk prostate cancer, highlighting current system limitations. He proposes a four-tier framework incorporating tumor volume, grade patterns, PSA levels, and PSMA PET findings to guide treatment intensification decisions. Biographies: Martin E. Gleave, CM, MD, FRCSC, FACS,...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Declan Murphy discusses DRE's evolving role in prostate cancer detection and staging. While noting its limited value in primary care and MRI-accessible settings, he emphasizes DRE's continued importance in regions lacking advanced imaging technologies. Biographies: Declan Murphy, Urologist and Director of Genitourinary Oncology, Pe...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Jochen Walz examines lymph node management in prostate cancer, addressing staging methods, PSMA PET's role in avoiding dissection, and ePLND's diagnostic and therapeutic value. He affirms ePLND as the staging gold standard, noting its benefits in reducing metastasis risk. Biographies: Jochen Walz, MD, Associate Professor in Urology...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Daniel Spratt explores biomarker-driven approaches beyond Gleason scoring for personalizing hormone therapy. He highlights how genomic classifiers and AI tools better predict treatment benefits, while emphasizing careful selection given cardiovascular risks of prolonged hormone therapy. Biographies: Daniel Spratt, MD, Chair and Pro...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Neal Shore leads a panel examining prostate cancer staging controversies, addressing DRE interpretation, MRI accessibility, lymph node dissection protocols, and biomarker testing across global healthcare settings. Biographies: Neal Shore, MD, FACS, Director, CPI (Certified Principal Investigator by the Association of Clinical Resea...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Neha Vapiwala examines modern radiation therapy in prostate cancer, discussing hypofractionation advances and focal boosts guided by MRI and PSMA PET. She addresses pelvic lymph node radiation debates and explores biomarker-driven strategies. Biographies: Neha Vapiwala, MD, FACR, FASTRO, FASCO, Professor of Radiation Oncology, Pere...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Alberto Briganti defends surgery's role in high-risk prostate cancer, challenging recent guideline changes. He discusses treatment de-intensification potential, lymph node dissection in PSMA-PET negative cases, and favorable outcomes from high-volume centers, while acknowledging the need for comparative trials. Biographies: Alberto...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Piet Ost challenges triple therapy in high-risk prostate cancer, showing doublet therapy achieves excellent outcomes with better quality of life. He emphasizes future intensification should target distant disease rather than local control, especially in multiple-risk patients. Biographies: Piet Ost, MD, PhD, Associate Professor (Fa...
|
- Details
- At the 2024 Advanced Prostate Cancer Consensus Conference (APCCC), Jason Efstathiou analyzes post-prostatectomy radiation therapy decisions, examining adjuvant versus early salvage approaches and risk stratification tools. He provides guidance on treatment timing and patient selection based on current trials and evidence. Biographies: Jason Efstathiou, MD, DPhil, FASTRO, FACRO, Professor of Radiat...
|
